Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis (Analytical method)

Go to Analytical method classification
NameTime-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis
ClassificationAnalytical methods > Ligand binding assay > Immunoassay

Publications with Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis

TitleFirst authorYear
Soya intake and plasma concentrations of daidzein and genistein: validity of dietary assessment among eighty British women (Oxford arm of the European Prospective Investigation into Cancer and Nutrition)Verkasalo2001
Validity and reproducibility of a self-administered food-frequency questionnaire to assess isoflavone intake in a japanese population in comparison with dietary records and blood and urine isoflavonesYamamoto2001
A semiquantitative food frequency questionnaire is a valid indicator of the usual intake of phytoestrogens by south Asian women in the UK relative to multiple 24-h dietary recalls and multiple plasma samplesBhakta2005
Intake of lignans is associated with serum enterolactone concentration in Finnish men and womenKilkkinen2003
Dietary determinants of plasma enterolactoneHorner2002
Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intakeArai2000
Short-term variations in enterolactone in serum, 24-hour urine, and spot urine and relationship with enterolactone concentrationsStumpf2003
Variation in fasting and non-fasting serum enterolactone concentrations in women of the Malmö Diet and Cancer cohortSonestedt2008
Biomarkers of dietary intake of flavonoids and phenolic acids for studying diet–cancer relationship in humansLinseisen2008

Biomarker data

Measurements of biomarkers by Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis

Concentration values

IDParent IDDepthSubject groupPopulationCountryCohortBiomarker Time definitionBiospecimenAnalytical methodBiomarkerBiomarker detailMeasurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianConverted unitAdjustment typeAdjusted onRegressed onExpressed asPublication

Reproducibility values

IDExcretion IDSubject groupPopulationCountryCohortBiomarker Time definitionBiospecimenAnalytical methodBiomarkerBiomarker detailArithmetic meanGeometric meanMedianUnitAdjusted onReproducibility sizeICCICC 95% CI lowerICC 95% CI upperCV% WSCV% BSVAR WSVAR BSPublication

Associations of biomarkers measured by Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis and exposures

Correlation values

IDIntake IDExcretion IDSubject groupPopulationCountryCohortIntake Time definitionIntake Assessment methodIntakeIntake detailSupplement intakes included?Intake Arithmetic meanIntake Geometric meanIntake MedianIntake UnitIntake Adjusted onBiomarker Time definitionBiospecimenAnalytical methodBiomarkerBiomarker detailBiomarker Arithmetic meanBiomarker Geometric meanBiomarker MedianBiomarker UnitBiomarker Adjusted onCorrelation sizeCorrelation typeCorrelation valueCorrelation 95% CI lowerCorrelation 95% CI upperCorrelation p-valueSignificant?Measurement adjustmentDeattenuated?CovariatesPublication

Metabolomic associations

IDIntake IDExcretion IDSubject groupPopulationCountryCohortNo. of subjectsIntake Assessment methodIntakeIntervention doseBiospecimenAnalytical methodBiomarkerStructural identificationFeature selectionArea under curveSensitivitySpecificityPLS-DA VIPBeta coefficientBeta coefficient p-valueANOVA p-valuePublication

Associations of biomarkers measured by Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis and cancer risk

Cancer associations

IDExcretion IDSubject groupPopulationCountryCohortNo. of subjectsNo. of casesNo. of controlsBiospecimenAnalytical methodBiomarkerBiomarker detailCancerStudy designPublication